GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka DD (WAR:KRK) » Definitions » Debt-to-EBITDA

Krka DD (WAR:KRK) Debt-to-EBITDA : 0.03 (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Krka DD Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Krka DD's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was zł16 Mil. Krka DD's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was zł41 Mil. Krka DD's annualized EBITDA for the quarter that ended in Sep. 2024 was zł1,649 Mil. Krka DD's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 was 0.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Krka DD's Debt-to-EBITDA or its related term are showing as below:

WAR:KRK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0.03   Max: 0.24
Current: 0.03

During the past 13 years, the highest Debt-to-EBITDA Ratio of Krka DD was 0.24. The lowest was 0.00. And the median was 0.03.

WAR:KRK's Debt-to-EBITDA is ranked better than
95.02% of 663 companies
in the Drug Manufacturers industry
Industry Median: 1.62 vs WAR:KRK: 0.03

Krka DD Debt-to-EBITDA Historical Data

The historical data trend for Krka DD's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka DD Debt-to-EBITDA Chart

Krka DD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.03 0.24 0.02 0.03

Krka DD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.02 0.02 0.03

Competitive Comparison of Krka DD's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Krka DD's Debt-to-EBITDA falls into.



Krka DD Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Krka DD's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(14.965 + 37.053) / 2047.038
=0.03

Krka DD's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(15.54 + 40.521) / 1648.556
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2024) EBITDA data.


Krka DD  (WAR:KRK) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Krka DD Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Krka DD's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka DD Business Description

Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.

Krka DD Headlines

No Headlines